Endorsements

The following individuals “share the goals of the Optimal Cancer Care Alliance and believe it is a clinical, financial, and ethical imperative to replace current oncology overdosing with optimal dosing. The right amount of medication at the right time reduces toxic side effects, provides the best clinical outcomes and lowers costs.”

 First NameLast NameTitle/PositionInstitutional Affiliation
Dr.AmolAkhadeNair Hospital, Mumbai
Dr. DanielAraujoMedical OncologistHospital de Base, Sao Jose do Rio Preto
Dr.ZebaAzizProfessorHameed Latif Hospital, Lahore, Pakistan
Dr. RajendraBadweDirectorTata Memorial Centre
Dr. DavidBaerSenior OncologistKaiser Permanente
Dr. GauthierBoucheThe Anticancer Fund
Dr. EmilianoCalvoDirector, Clinical ResearchSTART Madrid
Dr.MarkClemonsMedical OncologistThe Ottawa Hospital
Dr. PippaCorrieConsultant Medical OncologistCambridge University Hospitals NHS Foundation Trust
Dr. SarahDansonProfessor of Medical OncologyUniversity of Sheffield, UK
Dr. HelenaEarlProfessor EmeritusUniversity of Cambridge, Dept of Oncology
Dr. MakotoEndoKyushu University Hospital
Dr. DougFiggSenior InvestigatorNational Cancer Institute/NIH
Dr. VarshaGandhiProfessorMD Anderson Cancer Center
Dr. MarkGeraciNational PBM Clinical Pharmacy Program ManagerDept of Veterans Affairs
Dr.ErnestoGil DezaDirector of Education and ResearchInstituto Henry Moore
Dr. Boon-CherGohProfessorNational University Cancer Institute, Singapore
Dr. YasushiGotoNagasaki University Hospital
Dr.GwenaёlleGravis-MescamInstitut Paoli-Calmettes Marseille France
Dr. AlastairGreystokeSenior LecturerNewcastle University
Dr. ӦrvarGunnarssonMedical OncologyLandspitali, University Hospital, Iceland
Dr.IanHirschPrincess Margaret Cancer Centre
Dr. MichaelKelleyProfessor of MedicineDuke University
Dr. JennyKoMedical OncologistBC Cancer - Abbotsford
Dr. HideoKunitohJapanese Red Cross Medical Center
Dr. RuthLangleyProfessorMRC CTU at UCL
Dr. RayaLeibowitzHeadOncology Institute, Shamir Medical Center, Israel
Dr. AnneLoeserFounderPatient-Centered Dosing Initiative
Dr. HerbertLoongAssociate ProfessorThe Chinese University of Hong Kong
Dr. TakahiroOsawaHokkaido University
Dr. MaxParmarProfessorUCL
Dr.CodyPeerClinical PharmacologistNational Cancer Institute
Dr. MartinePiccartScientific Director, Institut Jules Bordet
Dr. RuthPlummerProfessor of Experimental Cancer MedicineNewcastle University, UK
Dr. RachelRiechelmannA.C Camargo Cancer Center
Dr. RobbeSaesenResearch FellowEORTC
Dr. TetsuoSaitoArao Municipal Hospital
Dr. LesleySeymourDirector, IND Program, Deputy Director, CCTG, Professor, Queens University
Dr. LillianSiuMedical OncologistPrincess Margaret Cancer Centre
Dr.GabeSonkeProfessorNetherlands Cancer Institute
Dr. WalterStadlerProfessor of MedicineUniversity of Chicago
Dr. MartinStocklerProfessor of Oncology and Clinical EpidemiologyNHRMC Clinical Trials Centre, University of Sydney
Dr. ShinnosukeTakemotoNagasaki University Hospital
Dr. Jonathan WadsleyProfessorWeston Park Cancer Centre, Sheffield UK

(Institutional affiliations are listed for identification purposes only)